My co-author’s lede:
In recent months, medical schools, the drug industry and Congress have sought to crack down on perceived conflicts of interest between physicians and drug companies. Now the Institute of Medicine has joined the calls for change.
The IOM issued a report April 28 warning that such conflicts could undermine the integrity of medicine, and the agency wants everyone involved in physician-drug industry relationships to rethink how they do business. The new approaches should be crafted with full disclosure at their core, the report said.
The whole shebang.